title: Six-year molecular analysis of Burkholderia cepacia complex isolates among cystic fibrosis patients at a referral center for lung transplantation.
abstract: Over a 6-year period, Burkholderia cepacia complex species were isolated from cystic fibrosis (CF) patients receiving care at The University of North Carolina Hospitals (clinic CF patients) and from those referred from other treatment centers. Fifty-six isolates collected from 30 referred patients and 26 clinic CF patients were characterized by pulsed-field gel electrophoresis (PFGE) and were assayed by PCR to detect the cable pilin gene, cblA. PFGE results indicated that six separate clusters (clusters A to F) were present among the 56 isolates and that three clusters (clusters A, B, and E) consisted only of isolates from referred patients infected with B. cepacia complex isolates prior to referral. However, one cluster (cluster C) consisted of isolates from four CF patients, and hospital records indicate that this cluster began with an isolate that came from a referred patient and that spread to three clinic CF patients. Cluster D consisted of two isolates from clinic CF patients, and hospitalization records are consistent with nosocomial, patient-to-patient spread. cblA was present in only 4 of the 56 isolates and included isolates in cluster E from the referred patients. Our results indicate a lack of spread of a previously characterized, transmissible clone from referred patients to our clinic CF population. Only two instances of nosocomial, patient-to-patient spread could be documented over the 6-year period. An additional spread of an isolate (cluster F) from a referred patient to a clinic patient could not be documented as nosocomial and may have been the result of spread in a nonhospitalized setting. The majority (36 of 56) of our B. cepacia complex-infected CF patients harbor isolates with unique genotypes, indicating that a diversity of sources account for infection. These data suggest that CF patients infected with B. cepacia complex and referred for lung transplantation evaluation were not a major source of B. cepacia complex strains that infected our resident CF clinic population.
authors.affiliation: Clinical Microbiology-Immunology Laboratories, University of North Carolina Hospitals, Chapel Hill 27514, USA.
authors.forename: David G
authors.initials: DG
authors.lastname: Heath
authors.forename: Kathy
authors.initials: K
authors.lastname: Hohneker
authors.forename: Charlene
authors.initials: C
authors.lastname: Carriker
authors.forename: Kelly
authors.initials: K
authors.lastname: Smith
authors.forename: Jonathan
authors.initials: J
authors.lastname: Routh
authors.forename: John J
authors.initials: JJ
authors.lastname: LiPuma
authors.forename: Robert M
authors.initials: RM
authors.lastname: Aris
authors.forename: David
authors.initials: D
authors.lastname: Weber
authors.forename: Peter H
authors.initials: PH
authors.lastname: Gilligan
mesh_terms: D019121:Burkholderia Infections / Q000382:microbiology*; D016956:Burkholderia cepacia / Q000145:classification* / Q000235:genetics* / Q000302:isolation & purification; D003550:Cystic Fibrosis / Q000382:microbiology*; D016521:Electrophoresis, Gel, Pulsed-Field; D036781:Fimbriae Proteins; D006801:Humans; D016040:Lung Transplantation; D008565:Membrane Proteins / Q000235:genetics; D016133:Polymerase Chain Reaction; D012017:Referral and Consultation
chemical_list: D008565:Membrane Proteins; D036781:Fimbriae Proteins